| Trial ID: | L6126 |
| Source ID: | NCT00440375
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Obesity|Menopause
|
| Interventions: |
DRUG: Rosiglitazone
|
| Outcome Measures: |
Primary: metabolic bone markers before and after the intervention, | Secondary: association between the changes in bone turnover parameters and plasma cytokine levels
|
| Sponsor/Collaborators: |
Sponsor: Baskent University
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
82
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2005-06
|
| Completion Date: |
2006-03
|
| Results First Posted: |
|
| Last Update Posted: |
2007-02-27
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00440375
|
